Home › MolMed a new patent on its anticancer NGR-hTNF
 

Keywords :   


MolMed a new patent on its anticancer NGR-hTNF

2013-09-11 20:07:47| Logistics - Topix.net

MolMed S.p.A. announces today receipt of the official notification from the European Patent Office of the decision to grant a patent covering the therapeutic use of its investigational anticancer drug NGR-hTNF at low doses.

Tags: patent anticancer

Category:Transportation and Logistics

Latest from this category

All news
23.11Atlantic Tropical Weather Outlook
23.11Eastern North Pacific Tropical Weather Outlook
23.11Atlantic Tropical Weather Outlook
23.11Eastern North Pacific Tropical Weather Outlook
22.11Eastern North Pacific Tropical Weather Outlook
22.11Atlantic Tropical Weather Outlook
22.11Eastern North Pacific Tropical Weather Outlook
22.11Atlantic Tropical Weather Outlook
Transportation and Logistics »
23.11 SP 4
23.1122SSS64UL-S
23.11
23.11725 TYPE H
23.11 3
23.11 Studiologic NumaCompact2
23.11Switch EL Pro
23.11 22
More »